128833-97-6

Basic information

• Product Name: 3,5-Dichloro-DL-Phenylalanine
• Synonyms: 3,5-Dichloro-DL-Phenylalanine;H-DL-Phe(3,5-Cl2)-OH;3,5-Dichloro-DL-Phenylalanine hydrochloride;2-Amino-3-(3,5-dichlorophenyl)propanoic acid hydrochloride
• CAS NO: 128833-97-6
• Molecular Formula: C₉H₉Cl₂NO₂*ClH
• Molecular Weight: 234.07926
• Mol File: 128833-97-6.mol
• Article Data: 2

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 3,5-Dichloro-DL-Phenylalanine(CAS DataBase Reference)
• NIST Chemistry Reference: 3,5-Dichloro-DL-Phenylalanine(128833-97-6)
• EPA Substance Registry System: 3,5-Dichloro-DL-Phenylalanine(128833-97-6)

Safety Data

• Hazardous Substances Data: 128833-97-6(Hazardous Substances Data)

Usage

General Description

3,5-Dichloro-DL-Phenylalanine is a chemical compound that consists of two chlorine atoms attached to a phenylalanine molecule. It is a derivative of the amino acid phenylalanine, which is essential for the synthesis of proteins in the human body. This chemical may have potential applications in pharmaceuticals and research due to its unique structure and properties. However, it should be handled with care and in accordance with proper safety protocols, as exposure to high levels of 3,5-Dichloro-DL-Phenylalanine can be hazardous to health. Overall, this compound has the potential for various industrial and research applications but should be used with caution.

Upstream product

• 115491-81-1 2-acetylamino-2-(3,5-dichlorobenzyl)malonic acid diethyl ester 
• 3290-06-0 1,3-dichloro-5-chloromethyl-benzene 
• 1068-90-2 2-acetylaminomalonic acid diethyl ester 

Downstream Products

• 856571-35-2 3-(3,5-dichlorophenyl)-2-{2-[(1H-indole-2-carbonyl)amino]benzoylamino}propionic acid ethyl ester 
• 856571-16-9 2-(2-aminobenzoylamino)-3-(3,5-dichlorophenyl)propionic acid ethyl ester 

Relevant articles and documents

Anthranilic acid based CCK1 receptor antagonists: Preliminary investigation on their second "touch point"

In this phase of structure-affinity relationship study of VL-0395, a new anthranilic acid based CCK1 selective antagonist, we propose a series of unnatural aminoacidic derivatives. The result of this work is the identification of a new CCK ligand, which possesses an affinity (IC50 = 35 nm) one order of magnitude greater than the lead and, as a general rule, it points out how the hypothesized receptorial pocket which accommodates the Phe residue allows much more structural modification than that interacting with the N-terminal group. Hence, the modification of the C-terminal pharmacophoric group of our lead VL-0395 can not only enhance the affinity of anthranilic acid derivatives but can modulate the selectivity for one CCK receptor subtype or afford mixed antagonists.